Global Information
회사소개 | 문의

탈장 수술 기기 : 의료기기 파이프라인 평가

Hernia Repair Devices - Medical Devices Pipeline Assessment, 2018

리서치사 GlobalData
발행일 2018년 08월 상품 코드 479838
페이지 정보 영문 97 Pages
가격
US $ 2,500 ₩ 2,863,700 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,727,500 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 8,591,200 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


탈장 수술 기기 : 의료기기 파이프라인 평가 Hernia Repair Devices - Medical Devices Pipeline Assessment, 2018
발행일: 2018년 08월 페이지 정보 : 영문 97 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

탈장 수술 기기(Hernia Repair Devices) 파이프라인 제품에 대해 조사 분석했으며, 개발 단계별 비교 분석에 초점을 맞추어 파이프라인 제품 개발 참여 주요 기업, 진행중인 임상시험 관련 정보 등을 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 탈장 수술 기기 개요

제3장 개발중인 제품

  • 탈장 수술 기기 - 파이프라인 제품 : 개발 단계별
  • 탈장 수술 기기 - 파이프라인 제품 : 부문별
  • 탈장 수술 기기 - 파이프라인 제품 : 영역별
  • 탈장 수술 기기 - 파이프라인 제품 : 제어 경로별
  • 탈장 수술 기기 - 파이프라인 제품 : 추정 승인일별
  • 탈장 수술 기기 - 현재 진행중인 임상시험

제4장 탈장 수술 기기 - 개발중인 파이프라인 제품 : 기업별

  • 탈장 수술 기기 기업 - 파이프라인 제품 : 개발 단계별
  • 탈장 수술 기기 - 파이프라인 제품 : 개발 단계별

제5장 탈장 수술 기기 기업 및 제품 개요

  • Acera Surgical, Inc. Company
  • Advanced Medical Solutions Group plc Company
  • ARISTE Medical Company
  • ArTack Medical Ltd Company
  • Atrium Medical Corp Company
  • C. R. Bard Inc Company
  • Cleveland Clinic Hospital Company
  • Cytograft Tissue Engineering Inc Company
  • DSM Biomedical BV Company
  • Kerecis ehf Company
  • LifeBond Ltd. Company
  • Medprin Regenerative Medical Technologies Co Ltd Company
  • MicroPort Scientific Corp Company
  • Montana State University Company
  • Nanovis Incorporated Company
  • Soft Tissue Regeneration Inc Company
  • TissueGen Inc Company
  • University of Colorado Company

제6장 탈장 수술 기기 - 최근의 발전

제7장 부록

LSH 17.10.20

1.1 List of Tables

  • Table 1: Hernia Repair Devices - Pipeline Products by Stage of Development 8
  • Table 2: Hernia Repair Devices - Pipeline Products by Segment 9
  • Table 3: Hernia Repair Devices - Pipeline Products by Territory 10
  • Table 4: Hernia Repair Devices - Pipeline Products by Regulatory Path 11
  • Table 5: Hernia Repair Devices - Pipeline Products by Estimated Approval Date 12
  • Table 6: Hernia Repair Devices - Ongoing Clinical Trials 13
  • Table 7: Hernia Repair Devices Companies - Pipeline Products by Stage of Development 14
  • Table 8: Hernia Repair Devices - Pipeline Products by Stage of Development 15
  • Table 9: Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 10: Surgical Mesh - Hernia - Product Status 16
  • Table 11: Surgical Mesh - Hernia - Product Description 16
  • Table 12: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 13: LiquiBand Fix8 - Product Status 17
  • Table 14: LiquiBand Fix8 - Product Description 18
  • Table 15: Liquiband Fix8 Adhesive - Open Hernia Repair - Product Status 18
  • Table 16: Liquiband Fix8 Adhesive - Open Hernia Repair - Product Description 18
  • Table 17: Advanced Medical Solutions Group plc - Ongoing Clinical Trials Overview 19
  • Table 18: LiquiBand Fix8 - Cyanoacrylate Fixation for Laparoscopic Repair of Inguinal Hernias: A Prospective, Multicenter Registry 20
  • Table 19: LiquiBand Fix8 - Randomized Single-center Study on Laparoscopic Groin Hernia Repair by a 3D ENDOLAP Visible with and Without LiquiBand Fix 8 Mesh Fixation 20
  • Table 20: LiquiBand Fix8 - Tacks versus Glue for Mesh Fixation in Laparoscopic Ventral Hernia Repair Treating Defects Between 2 and 5 cm Diameter: A Multicenter Randomized Controlled Study 20
  • Table 21: Aran Biomedical Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 22: Mi-Mesh - Product Status 21
  • Table 23: Mi-Mesh - Product Description 21
  • Table 24: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 25: Drug-eluting Hernia Mesh - Product Status 22
  • Table 26: Drug-eluting Hernia Mesh - Product Description 22
  • Table 27: ArTack Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 28: eTack Device - Product Status 23
  • Table 29: eTack Device - Product Description 23
  • Table 30: Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 31: Next Generation Omega 3 Coated Surgical Mesh - Product Status 24
  • Table 32: Next Generation Omega 3 Coated Surgical Mesh - Product Description 24
  • Table 33: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 34: Phasix Expansion - Product Status 25
  • Table 35: Phasix Expansion - Product Description 25
  • Table 36: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 37: Reinforced Extracellular Matrix Device - Product Status 26
  • Table 38: Reinforced Extracellular Matrix Device - Product Description 26
  • Table 39: Cousin Biotech Sarl Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 40: Parietal Repair Implant - Product Status 27
  • Table 41: Parietal Repair Implant - Product Description 27
  • Table 42: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 43: Lifeguard Patch - Product Status 28
  • Table 44: Lifeguard Patch - Product Description 28
  • Table 45: Deep Blue Medical Advances Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 46: T-line Hernia Mesh - Product Status 29
  • Table 47: T-line Hernia Mesh - Product Description 29
  • Table 48: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 49: Hernia Glue - Product Status 30
  • Table 50: Hernia Glue - Product Description 30
  • Table 51: Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 52: Kerecis Omega3 Hernia - Product Status 31
  • Table 53: Kerecis Omega3 Hernia - Product Description 31
  • Table 54: LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 55: LifeMesh - Product Status 32
  • Table 56: LifeMesh - Product Description 32
  • Table 57: Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 58: RETISSUE Hernia Repair Patch - Product Status 33
  • Table 59: RETISSUE Hernia Repair Patch - Product Description 33
  • Table 60: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 61: Hernia Patch - Product Status 34
  • Table 62: Hernia Patch - Product Description 34
  • Table 63: Montana State University Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 64: Lipid-Coated Surgical Mesh - Product Status 35
  • Table 65: Lipid-Coated Surgical Mesh - Product Description 35
  • Table 66: Nanovis Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 67: Hernia Mesh - Product Status 36
  • Table 68: Hernia Mesh - Product Description 36
  • Table 69: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 70: CelGro - General Surgery - Product Status 37
  • Table 71: CelGro - General Surgery - Product Description 37
  • Table 72: Paradigm Surgical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 73: SafeClose Mesh Augmentation System - Product Status 38
  • Table 74: SafeClose Mesh Augmentation System - Product Description 38
  • Table 75: Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 76: 3D Surgical Mesh - Hernia Repair - Product Status 39
  • Table 77: 3D Surgical Mesh - Hernia Repair - Product Description 39
  • Table 78: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 79: SMP Hernia Repair Patch - Product Status 40
  • Table 80: SMP Hernia Repair Patch - Product Description 40
  • Table 81: Via Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 82: FasTouch Fixation System - Product Status 41
  • Table 83: FasTouch Fixation System - Product Description 41
  • Table 84: Glossary 96

1.2 List of Figures

  • Figure 1: Hernia Repair Devices - Pipeline Products by Stage of Development 8
  • Figure 2: Hernia Repair Devices - Pipeline Products by Segment 9
  • Figure 3: Hernia Repair Devices - Pipeline Products by Territory 10
  • Figure 4: Hernia Repair Devices - Pipeline Products by Regulatory Path 11
  • Figure 5: Hernia Repair Devices - Pipeline Products by Estimated Approval Date 12
  • Figure 6: Hernia Repair Devices - Ongoing Clinical Trials 13

영문목차

GlobalData's Medical Devices sector report, "Hernia Repair Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Hernia Repair Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hernia Repair Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hernia Repair Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hernia Repair Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hernia Repair Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Hernia Repair Devices Overview 7

3 Products under Development 8

  • 3.1 Hernia Repair Devices - Pipeline Products by Stage of Development 8
  • 3.2 Hernia Repair Devices - Pipeline Products by Segment 9
  • 3.3 Hernia Repair Devices - Pipeline Products by Territory 10
  • 3.4 Hernia Repair Devices - Pipeline Products by Regulatory Path 11
  • 3.5 Hernia Repair Devices - Pipeline Products by Estimated Approval Date 12
  • 3.6 Hernia Repair Devices - Ongoing Clinical Trials 13

4 Hernia Repair Devices - Pipeline Products under Development by Companies 14

  • 4.1 Hernia Repair Devices Companies - Pipeline Products by Stage of Development 14
  • 4.2 Hernia Repair Devices - Pipeline Products by Stage of Development 15

5 Hernia Repair Devices Companies and Product Overview 16

  • 5.1 Acera Surgical, Inc. Company Overview 16
    • 5.1.1 Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.2 Advanced Medical Solutions Group plc Company Overview 17
    • 5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.3 Aran Biomedical Company Overview 21
    • 5.3.1 Aran Biomedical Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.4 Ariste Medical LLC Company Overview 22
    • 5.4.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.5 ArTack Medical Ltd Company Overview 23
    • 5.5.1 ArTack Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.6 Atrium Medical Corp Company Overview 24
    • 5.6.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.7 C. R. Bard Inc Company Overview 25
    • 5.7.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.8 Cleveland Clinic Hospital Company Overview 26
    • 5.8.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.9 Cousin Biotech Sarl Company Overview 27
    • 5.9.1 Cousin Biotech Sarl Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 Cytograft Tissue Engineering Inc (Inactive) Company Overview 28
    • 5.10.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.11 Deep Blue Medical Advances Inc Company Overview 29
    • 5.11.1 Deep Blue Medical Advances Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.12 DSM Biomedical BV Company Overview 30
    • 5.12.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.13 Kerecis ehf Company Overview 31
    • 5.13.1 Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.14 LifeBond Ltd Company Overview 32
    • 5.14.1 LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.15 Medprin Regenerative Medical Technologies Co Ltd Company Overview 33
    • 5.15.1 Medprin Regenerative Medical Technologies Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.16 MicroPort Scientific Corp Company Overview 34
    • 5.16.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.17 Montana State University Company Overview 35
    • 5.17.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.18 Nanovis Inc Company Overview 36
    • 5.18.1 Nanovis Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.19 Orthocell Ltd Company Overview 37
    • 5.19.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.20 Paradigm Surgical Devices LLC Company Overview 38
    • 5.20.1 Paradigm Surgical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.21 Soft Tissue Regeneration Inc Company Overview 39
    • 5.21.1 Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.22 University of Colorado Company Overview 40
    • 5.22.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.23 Via Surgical Ltd Company Overview 41
    • 5.23.1 Via Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

6 Hernia Repair Devices- Recent Developments 42

  • 6.1 Jul 06, 2018: Shanghai MicroPort Medical (Group) Won a Patent Right Lawsuit Against NewMed Medical 42
  • 6.2 Jun 28, 2018: Baxter Releases 2017 Corporate Responsibility Report and Reinforces Its Commitment to Enriching Communities Around the World 42
  • 6.3 Jun 27, 2018: MicroPort Hosts the Sixth Science and Technology Conference 43
  • 6.4 Jun 21, 2018: MicroPort Scientific Announces Change Of Non-Executive Director 44
  • 6.5 Jun 07, 2018: TELA Bio Announces Initial Data from BRAVO Study of OviTex Reinforced BioScaffolds for Ventral Hernia Repair 45
  • 6.6 Jun 06, 2018: Admedus Announces Conclusion Of Relationship With Go Medical 45
  • 6.7 Jun 06, 2018: Advanced Medical Solutions announces retirement of CFO 46
  • 6.8 May 23, 2018: Admedus Announce Appointment of Catherine Costello 46
  • 6.9 May 21, 2018: Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference 46
  • 6.10 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 48
  • 6.11 May 01, 2018: Admedus Names Michael Oswell As Vice President, Development 49

7 Appendix 94

  • 7.1 Methodology 94
  • 7.2 About GlobalData 97
  • 7.3 Contact Us 97
  • 7.4 Disclaimer 97
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research